Trading Signals: IOVA Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Iovance Biotherapeutics Inc)
| IOVA latest price $22.2500 (-1.98%) ($21.7800 - $22.7700) on Sun. Jan. 26, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.76% (three month average) | RSI | 34 | Latest Price | $22.2500(-1.98%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | IOVA declines -1.3% a day on average for past five trading days. | Weekly Trend | IOVA declines -6.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support IOVA advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting IOVA price | IOVA will decline at least -1.88% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.88% (StdDev 3.76%) | Hourly BBV | 0 () | Intraday Trend | -2% | | | |
|
1 - 5 Day Possible Target | $9.98(-55.15%) | Resistance Level | $25.36 | 5 Day Moving Average | $23.14(-3.85%) | 10 Day Moving Average | $23.79(-6.47%) | 20 Day Moving Average | $25.36(-12.26%) | To recent high | -24.3% | To recent low | 10% | Market Cap | $N/A | | | | Iovance Biotherapeutics, Inc. operates as a biotechnology company. The firm engages in the development and commercialization of novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes, or TIL, which are T cells derived from patients' tumors. The company was founded by Robert T. Brooke on September 17, 2007 and is headquartered in San Carlos, CA. |